Elliptic Laboratories ASA

OSE:ELABS.OL

17.56 (NOK) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NOK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q2
Assets:
Current Assets:
Cash & Cash Equivalents 96.89599.926115.582118.026130.432152.64176.437198.824212.833218.354216.827208.05577.76294.89698.5699.821
Short Term Investments 0000000000000000
Cash and Short Term Investments 96.89599.926115.582118.026130.432152.64176.437198.824212.833218.354216.827208.05577.76294.89698.5699.821
Net Receivables 79.19680.39966.97486.4976.36750.07247.33941.08314.81816.59829.02534.06721.36113.62600
Inventory 0000001.7820000-34.067-21.361-13.62600
Other Current Assets 13.24703.0860000.0617.9613.73810.44219.09734.71722.09114.109025.033
Total Current Assets 189.338180.325185.642206.017209.967204.023225.619247.867241.389245.394264.949242.77299.853109.005121.60134.854
Non-Current Assets:
Property, Plant & Equipment, Net 18.49119.77419.90721.0471.3691.6362.2561.1161.6742.2322.793.3483.9074.4655.0236.139
Goodwill 0000000000000000
Intangible Assets 64.6260.80357.81454.31251.94349.71447.57443.23540.89838.89936.56432.10930.76129.58828.24119.115
Goodwill and Intangible Assets 64.6260.80357.81454.31251.94349.71447.57443.23540.89838.89936.56432.10930.76129.58828.24119.115
Long Term Investments 7.2488.9238.8618.7168.1648.1645.0385.0035.0184.7654.5174.3154.0524.07200
Tax Assets 76.78178.22977.68572.04170.3672.37468.83764.90766.58165.7162.53466.12963.67962.27459.80761.054
Other Non-Current Assets 0-000.00200.001-0.0010000.0010.001004.052.092
Total Non-Current Assets 167.14167.729164.267156.118131.836131.889123.704114.261114.171111.606106.406105.902102.399100.39897.12188.4
Total Assets 356.478348.054349.909362.134341.803335.912349.324362.128355.561357371.356348.674202.252209.403218.722123.254
Liabilities & Equity:
Current Liabilities:
Account Payables 6.3623.7813.8553.6821.6171.0231.6681.1672.463.2083.0291.770.8861.3030.9891.047
Short Term Debt 410.1267.997.8774.7545.4896.1844.9615.5116.0616.6116.4336.1996.2036.2032.422
Tax Payables 004.760003.1040002.3090.3040.290.1982.2821.758
Deferred Revenue 5.6820000000008.4150.3040.290.19801.758
Other Current Liabilities 9.69812.63713.0817.7848.9869.8339.3276.2817.3576.8430.0016.6214.2755.7046.4247.419
Total Current Liabilities 25.74226.54424.92619.34315.35716.34517.17912.40915.32816.11218.05615.12811.6513.40813.61612.646
Non-Current Liabilities:
Long Term Debt 012.00119.7034.5425.5586.5237.538.539.5310.5312.22513.97715.4917.00245.104
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 013.85415.8740.001000.0010-0.00100.0010.0010000
Total Non-Current Liabilities 13.2214.85417.87519.7044.5425.5586.5247.538.5299.5310.53112.22613.97715.4917.00245.104
Total Liabilities 38.96241.39842.80139.04719.89921.90323.70319.93923.85725.64228.58727.35425.62728.89830.61857.749
Equity:
Preferred Stock 0000000000000000
Common Stock 1.0531.0481.0481.0461.0411.0411.0411.0411.0411.0381.0381.0310.9590.9580.9580.875
Retained Earnings 0000000000000000
Accumulated Other Comprehensive Income/Loss -43.37-49.394-48.942-29.981-24.651-32.546-20.934-4.366-14.503-12.225-0.8140.20814.11513.45800
Other Total Stockholders Equity 359.833355.002355.002352.022345.514345.514345.514345.514345.166342.545342.545320.081161.551166.089187.14664.629
Total Shareholders Equity 317.516306.656307.108323.087321.904314.009325.621342.189331.704331.358342.769321.32176.625180.505188.10465.504
Total Equity 317.516306.656307.108323.087321.904314.009325.621342.189331.704331.358342.769321.32176.625180.505188.10465.504
Total Liabilities & Shareholders Equity 356.478348.054349.909362.134341.803335.912349.324362.128355.561357371.356348.674202.252209.403218.722123.254